A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)

J. G. Aerts*, H. Codrington, N. A. G. Lankheet, S. Burgers, B. Biesma, A. -M. C. Dingemans, A. D. Vincent, O. Dalesio, H. J. M. Groen, E. F. Smit

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

34 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2860-2865
JournalAnnals of Oncology
Issue number11
Publication statusPublished - Nov 2013


  • second line
  • intercalated
  • erlotinib

Cite this